VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 2 filers reported holding VECTIVBIO HLDG AG in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2023 | $315,304 | -1.7% | 37,051 | 0.0% | 0.23% | -9.9% |
| Q4 2022 | $320,862 | +44.5% | 37,051 | 0.0% | 0.25% | +180.0% |
| Q3 2022 | $222,000 | +11.0% | 37,051 | 0.0% | 0.09% | +26.8% |
| Q2 2022 | $200,000 | +14.3% | 37,051 | 0.0% | 0.07% | -2.7% |
| Q1 2022 | $175,000 | -3.8% | 37,051 | 0.0% | 0.07% | +55.3% |
| Q4 2021 | $182,000 | – | 37,051 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,782,756 | $46,945,093 | 14.24% |
| TCG Crossover Management, LLC | 3,113,600 | $52,931,200 | 8.68% |
| Chicago Capital Management, LLC | 173,840 | $2,955,280 | 3.79% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 642,769 | $10,843,513 | 3.65% |
| Versor Investments LP | 1,210,379 | $20,419,094 | 3.54% |
| Crabel Capital Management, LLC | 460,405 | $7,767 | 3.20% |
| Kellner Capital, LLC | 145,597 | $2,475 | 2.84% |
| Vivo Capital, LLC | 2,333,300 | $39,362,771 | 2.72% |
| GLAZER CAPITAL, LLC | 1,875,178 | $31,878 | 2.11% |
| Orbimed Advisors | 5,156,561 | $87,661,537 | 1.59% |